BioViva Announces U.S. Patent for Klotho Gene Therapy Targeting Age-Related Cognitive Decline
Patent No. 12,564,646 Covers the Use of Klotho and hTERT Gene Therapy for Age-Related Cognitive Decline BAINBRIDGE ISLAND, Wash., Sept. 1, 2026 /PRNewswire/ -- BioViva USA, Inc., a biotechnology company developing therapies targeting the biological mechanisms of aging, today announced the...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.